#binance #hype #zec #near
14/07/25 16:13 UTC-04

Sonnet BioTherapeutics Shares Surge 260% After Crypto Deal

Shares of the biopharmaceutical company Sonnet BioTherapeutics surged sharply after the announcement of a merger with an $888 million organization aiming to enter the cryptocurrency market.

Sonnet’s shares, which closed at $5.17 on Friday, jumped to $18.68 before the market opened (an increase of 265%). Since the start of the year, SONN shares have risen by more than 220%, though today their price corrected by about 2% down.

Daily price chart of SONN shares. Source: Google Finance.

This surge was driven by Sonnet’s agreement with Rorschach I LLC, backed by Atlas Merchant Capital and Paradigm Operations, to form a new company called Hyperliquid Strategies Inc.

Effectively, the deal will transform Sonnet into a publicly traded crypto treasury company specializing in holding and increasing reserves of HYPE tokens.

Under the terms of the agreement, Hyperliquid Strategies will hold approximately 12.6 million HYPE tokens valued at around $583 million, as well as at least $305 million in cash. The total value of the deal is estimated at $888 million.

In addition to the initial reserves in HYPE and cash, Hyperliquid Strategies plans to use its capital to acquire even more HYPE tokens.

The deal is expected to close in the coming months, pending regulatory and shareholder approval.

See also: "U.S. Democrats Declare ‘Crypto Corruption Week’ Against Trump"

#Sonnet #Price Increase

Editor: Pereyidenko Ihor
Comments

Similar

08/06/26 18:29 UTC-04

NEAR Overcomes Market Weakness With a 20% Rebound

$NEAR recovered by roughly 20% from its recent low, outperforming other digital assets that are still struggling to recover. Market analyst Michaël van de Poppe called the token one of the strongest assets in the market and linked its next move to Bitcoin’s performance.

08/06/26 06:03 UTC-04

ZEC Rises 41.5% After Critical Network Vulnerability

Zcash Open Development Lab (ZODL) founder Josh Swihart reported that a critical vulnerability in the Orchard shielded pool had been fixed. Against this backdrop, the asset’s price began to recover after a major decline.